Novel Enterprises Corp

Novel Enterprises Corp, a minority-owned, Hispanic American-owned, SBA-certified 8(a) small disadvantaged business based in San Juan, Puerto Rico, provides facility operations, maintenance, and civil-mechanical-electrical repair services to the Food and Drug Administration as a prime contractor under total small business set-asides. The vendor operates exclusively as a prime contractor, with 100% of recent awards concentrated in a single-award indefinite-delivery contract for facility management at the FDA's San Juan District Office.

Novel's footprint is entirely FDA-focused. All six prime awards and the full $15.4 million in combined potential value flow through the Department of Health and Human Services Food and Drug Administration; the vendor has no customer diversification across other federal agencies. Four task orders worth $7.8 million in combined potential value operate under a single IDC (75F40124D00010) with a base period of three months plus four one-year option periods, extending through June 17, 2027 with a total ceiling of $7.2 million. Recent delivery orders exemplify the vendor's capability scope: a $5.4 million operations and maintenance order (awarded February 9, 2024, extending through June 2029 and generating $474 thousand in SCI-reportable invoiced labor in FY2024); a $906 thousand order for integration of main HVAC systems to the FDA's building management system (awarded September 23, 2024, completed September 29, 2025); a $385 thousand order for civil, mechanical, and electrical repairs and equipment replacement across the San Juan campus (awarded August 5, 2024, completing August 30, 2025); a chiller unit replacement contract valued at $444 thousand (awarded September 21, 2025, completed May 5, 2026); and a $135 thousand delivery order for emergency stormwater concrete pipe repair at San Juan National Historic Site (awarded August 21, 2026, completing February 20, 2027). All work is performed in San Juan, Puerto Rico.

Activity has contracted sharply since the initial IDC award in early 2024: four awards placed in 2024, one in 2025, and one in 2026. Only one award ($135 thousand) completes within the next twenty-four months, creating minimal near-term recompete risk. SCI-reported invoicing shows $474 thousand in FY2024 across 5.2 FTEs with no FY2025 records in the SCI dataset; government-paid hourly rates on SCI-reportable labor ran from a 10th percentile of $4.39/hr to a median of $21.96/hr to a 90th percentile of $39.53/hr. The vendor self-performs all labor with zero subcontractor engagement across reported prime contracts. Novel's narrow customer base and single-vendor relationship create dependence on the FDA's San Juan facility footprint and render the vendor vulnerable to budget constraints, consolidation, or competitive recompete on the IDC vehicle.

The main line of business of Novel Enterprises is to provide facilities operations management, grounds, landscaping, and engineering consulting and services. This work includes tasks such as management, supervision, labor, certifications, engineering design, materials, equipment maintenance (Electrical, HVAC, Plumbing, Communications, Controls), and supplies in facilities.